These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5428757)

  • 1. Pre-ulcerative buruli lesions.
    Phillips I
    Br Med J; 1970 Jun; 2(5712):792. PubMed ID: 5428757
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical features and treatment of pre-ulcerative Buruli lesions (Mycobacterium ulcerans infection). Report II of the Uganda Buruli Group.
    Br Med J; 1970 May; 2(5706):390-3. PubMed ID: 5420605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rural district in Ghana.
    Amofah G; Asamoah S; Afram-Gyening C
    Trop Doct; 1998 Apr; 28(2):81-3. PubMed ID: 9594673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The local immune response in ulcerative lesions of Buruli disease.
    Kiszewski AE; Becerril E; Aguilar LD; Kader IT; Myers W; Portaels F; Hernàndez Pando R
    Clin Exp Immunol; 2006 Mar; 143(3):445-51. PubMed ID: 16487243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relapse after surgical treatment of mycobacterium ulcerans infection (buruli ulcer): study of risk factors in 84 patients in the Democratic Republic of the Congo].
    Kibadi K; Mputu-Yamba JB; Mokassa B; Panda M; Muyembe-Tamfum JJ
    Med Trop (Mars); 2009 Oct; 69(5):471-4. PubMed ID: 20025176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium ulcerans infection.
    van der Werf TS; van der Graaf WT; Tappero JW; Asiedu K
    Lancet; 1999 Sep; 354(9183):1013-8. PubMed ID: 10501380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Impact of Buruli ulcer secondary prevention program in an endemic area in Côte d'Ivoire].
    Kanga JM; Kacou ED; Yao JK; Kassi K; Kouamé K; Kaloga M; Kamelan CO
    Bull Soc Pathol Exot; 2007 Oct; 100(4):277-81. PubMed ID: 17982859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rates of apoptosis in human Mycobacterium ulcerans culture-positive buruli ulcer skin lesions.
    Walsh DS; Meyers WM; Portaels F; Lane JE; Mongkolsirichaikul D; Hussem K; Gosi P; Myint KS
    Am J Trop Med Hyg; 2005 Aug; 73(2):410-5. PubMed ID: 16103613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The "Buruli Score": Development of a Multivariable Prediction Model for Diagnosis of Mycobacterium ulcerans Infection in Individuals with Ulcerative Skin Lesions, Akonolinga, Cameroon.
    Mueller YK; Bastard M; Nkemenang P; Comte E; Ehounou G; Eyangoh S; Rusch B; Tabah EN; Trellu LT; Etard JF
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004593. PubMed ID: 27045293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of Buruli disease.
    Barker DJ; Clancey JK; Morrow RH; Rao S
    Br Med J; 1970 Nov; 4(5734):558. PubMed ID: 5488702
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study.
    Vincent QB; Ardant MF; Adeye A; Goundote A; Saint-André JP; Cottin J; Kempf M; Agossadou D; Johnson C; Abel L; Marsollier L; Chauty A; Alcaïs A
    Lancet Glob Health; 2014 Jul; 2(7):e422-30. PubMed ID: 25103396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG vaccination against mycobacterium ulcerans infection (Buruli ulcer). First results of a trial in Uganda.
    Lancet; 1969 Jan; 1(7586):111-5. PubMed ID: 4178240
    [No Abstract]   [Full Text] [Related]  

  • 13. Short report: Clinical and molecular evidence for a case of Buruli ulcer (Mycobacterium ulcerans infection) in Kenya.
    Walsh DS; Eyase F; Onyango D; Odindo A; Otieno W; Waitumbi JN; Bulimo WD; Schnabel DC; Meyers WM; Portaels F
    Am J Trop Med Hyg; 2009 Dec; 81(6):1110-3. PubMed ID: 19996445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buruli ulcer in New York City.
    Lindo SD; Daniels F
    JAMA; 1974 May; 228(9):1138-9. PubMed ID: 4406435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Stefansky's serodiagnosis and ulcerative and mutilating acropathy (author's transl)].
    Barrière H; Roubeix Y
    Ann Dermatol Venereol; 1978 Apr; 105(4):417-9. PubMed ID: 686616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in Mycobacterium ulcerans disease (Buruli ulcer) in the Lalo District of Bénin (West Africa).
    Anagonou EG; Johnson RC; Barogui YT; Sopoh GE; Ayelo GA; Wadagni AC; Houezo JG; Agossadou DC; Boko M
    BMC Infect Dis; 2019 Mar; 19(1):247. PubMed ID: 30871489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.
    Zingue D; Bouam A; Tian RBD; Drancourt M
    Clin Microbiol Rev; 2018 Jan; 31(1):. PubMed ID: 29237707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease.
    Herbinger KH; Adjei O; Awua-Boateng NY; Nienhuis WA; Kunaa L; Siegmund V; Nitschke J; Thompson W; Klutse E; Agbenorku P; Schipf A; Reu S; Racz P; Fleischer B; Beissner M; Fleischmann E; Helfrich K; van der Werf TS; Löscher T; Bretzel G
    Clin Infect Dis; 2009 Apr; 48(8):1055-64. PubMed ID: 19275499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methods used in preclinical assessment of anti-Buruli ulcer agents: A global perspective.
    Tsouh PV; Addo P; Yeboah-Manu D; Boyom FF
    J Pharmacol Toxicol Methods; 2015; 73():27-33. PubMed ID: 25792087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.